We are live on
!
Find out more
Halozyme
HALO
HALO
110 hedge funds and large institutions have $603M invested in Halozyme in 2013 Q2 according to their latest regulatory filings, with 110 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
22% less call options, than puts
Call options by funds: $5.37M | Put options by funds: $6.88M
Holders
110
Holders Change
+110
Holders Change %
–
% of All Funds
3.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
110
Increased
–
Reduced
–
Closed
–
Calls
$5.37M
Puts
$6.88M
Net Calls
-$1.51M
Net Calls Change
-$1.51M
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
HALO Hedge Fund Activity: Q2 2013 in Review
110 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2013, worth a combined $603M.
Buyers outnumbered sellers: 110 funds opened new HALO positions and 0 closed out — a net gain of 110 holders — while 0 added to existing stakes and 0 trimmed.
- 110 institutional investors held Halozyme (HALO) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $603M of Halozyme stock for Q2 2013.
- 110 funds opened new Halozyme positions in Q2 2013 and 0 closed out, a net change of +110 holders.
Based on aggregated 13F filings for Q2 2013.